Blog•Mar 30, 2026
Monday March 30, 2026
The medical device landscape is accelerating across multiple fronts. Medtronic secured FDA clearance to extend its robotic platform into cranial and ENT surgeries, while Boston Scientific introduced a fluid‑management system for ureteroscopy. At‑home neuromodulation received a $6 million infusion after FDA approval, and Butterfly Network launched an AI‑driven ultrasound that estimates gestational age in minutes. Meanwhile, VITL raised $7.5 million to build interoperable health‑software infrastructure, underscoring broader shifts toward decentralized care and data connectivity.
